Raffles Medical Group revenue surges to $343.8m in H1

The group’s profits after tax ballooned by as much as 138.4%.

Raffles Medical Group revenue saw an increase of 42.4% to $343.8m in the first half (H1) of 2021 compared to $241.42m in the same period last year.

Additionally, profits after tax grew to $38.84m in H1 2021 from $16.29m in the same period last year, an estimated 138.4% increase.

According to the group, the increase is attributed to its active role with the government in its COVID-19 vaccination and Polymerase Chain Reaction swab tests initiatives.

“Against this backdrop, revenue from the healthcare and hospital services divisions grew by 65.4% and 35.4%, respectively. The group’s earnings before interest, taxes, depreciation, and amortisation increased by 78% from $41.9m in H1 2020 to $74.5m in H1 2021. Its profit after tax and minority interests grew by 128.7% from $17.2m in H1 2020 to $39.4m in H1 2021,” Raffles Medical said.

For the transition year FY 2021, the group expects to pay a total core dividend of not less than $2.5c per share.

Barring unforeseen circumstances, the group said it expects to be more profitable in FY 2021 than last year.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Thanks to the renewal of interest in the Singapore market.
The electronics cluster showed the most optimism.
The initiative aims to improve the overseas service exports environment.
This is the group’s 2nd sustainability notes issuance in the SGD bond market.
A Jefferies report said Singapore banks have enough buffers.
HongkongLand, CapitaLandInvest, and ComfortDelGro showed the most growth.
Mizuho Securities Asia Limited will be the notes dealer.
The company’s first batch has been fully allocated in the country.
The total consideration of up to $539m over three years will take effect. 
This is to address the increased global demand for healthcare products.
Thanks to the company's improved distribution channels.
Hiring activities online increased by 55.7% in August.
CapitaLandInvest, Capland IntCom T, and Sembcorp Industries showed the most growth.
This low turnout is due to the large quantum of the project, experts say.